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Abstract 
In renal cells, hyperosmolarity can induce cellular stress or differentiation. Both processes require 
active endoplasmic reticulum (ER)-associated protein synthesis. Lipid biosynthesis also occurs at ER 
surface. We showed that hyperosmolarity upregulates glycerophospholipid (GP) and triacylglycerol 
(GL-TG) de novo synthesis. Considering that massive synthesis of proteins and/or lipids may drive to 
ER stress, herein we evaluated whether hyperosmolar environment induces ER stress and the 
participation of inositol-requiring enzyme 1 (IRE1)-XBP1 in hyperosmotic-induced lipid synthesis. 
Treatment of Madin-Darby canine kidney (MDCK) cells with hyperosmolar medium triggered ER 
stress-associated unfolded protein response (UPR). Hyperosmolarity significantly increased xbp1 
mRNA and protein as function of time; 24 h of treatment raised the spliced form of XBP1 protein 
(XBP1s) and induced its translocation to nuclear compartment where it can act as a transcription 
factor. XBP1 silencing or IRE1 ribonuclease (RNAse) inhibition impeded the expression of lipin1, 
lipin2 and diacylglycerol acyl transferase-1 (DGAT1) enzymes which yielded decreased GL-TG 
synthesis. The lack of XBP1s also decreased sterol regulatory element binding protein (SREBP) 1 and 
2. Together our data demonstrate that hyperosmolarity induces IRE1XBP1s activation; XBP1s 
drives the expression of SREBP1 and SREBP2 which in turn regulates the expression of the lipogenic 
enzymes lipin1 (LPIN1) and 2 (LPIN2) and DGAT1. We also demonstrated for the first time that 
tonicity-responsive enhancer binding protein (TonEBP), the master regulator of osmoprotective 
response, regulates XBP1 expression. Thus, XBP1 acts as an osmoprotective protein since it is 
activated by high osmolarity and upregulates lipid metabolism, membranes generation and the 
restoration of ER homeostasis 
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diacylglycerol; GL-TG, triacylglycerol; LD, lipid droplets; SREBP, sterol regulatory element binding 














3 Casali & Malvicini et al 
1. Introduction.  
Hyperosmolarity is a key controversial signal for renal cells. Under physiological conditions, it 
induces renal cell differentiation and maturation of urine concentrating system. High interstitial 
osmolarity is necessary to concentrate urine in mature kidneys [1-3]. However, abrupt changes in 
environmental osmolarity may induce cell stress that can lead to death. Interestingly, both processes 
require an active synthesis of proteins either related to renal function in differentiated cells or related 
to osmoprotection [2-5]. In addition, we demonstrated that hyperosmolarity upregulates lipid 
metabolism in renal cells, by activating the transcription of lipogenic genes such as fatty acid synthase 
(fas), lipins, diacylglycerol acyltransferase (dgat) and the transcriptional regulator sterol regulatory 
element-binding protein (srebp) [6-8]. Hyperosmolar activation of lipid metabolism is a requirement 
as an osmoprotective mechanism by preserving membrane structure as well as a physiological tool in 
differentiation by constructing cell structure and tissue architecture. 
 Most lipids, glycerophospholipids (GP), trilglycerols (GL-TG), cholesterol and ceramide 
biosynthesis occur at the endoplasmic reticulum (ER). In addition, ER plays a central role in calcium 
storage and homeostasis, and in membrane-, secretory- and lysosomal-proteins synthesis, folding and 
post-translational modifications [9, 10]. In response to several stimuli, an abrupt protein synthesis may 
occur leading to an accumulation of macromolecular aggregates of misfolded proteins within ER 
lumen, which causes the disruption of ER homeostasis, known as ER stress. To restore ER 
homeostasis, the unfolded protein response (UPR) is activated. The UPR is an intracellular signaling 
pathway that transmits signals from the ER lumen in order to activate gene transcription. As 
consequence of UPR activation, ER protein-folding capacity is improved by increasing the expression 
of chaperones and foldases as well as the expansion of the ER membranes. If ER stress is not resolved, 
cell death occurs [11]. ER stress activates UPR by means of three ER transmembrane transducers: the 
inositol-requiring enzyme kinase 1 (IRE1), the pancreatic ER kinase (PERK), and the activating 
transcription factor 6 (ATF6). In normal conditions, all these three proteins bind to a chaperone named 
binding immunoglobulin protein (BiP), also known glucose-regulated protein 78 (GRP78), through 
their luminal domains. Under stress conditions, BiP binds to misfolded proteins causing its 
dissociation from IRE1, ATF6 and/or PERK. These proteins suffer a conformational change that 












4 Casali & Malvicini et al 
the restoration of cell homeostasis [11].  
 Activated-IRE1 pathway drives IRE1-endoribonuclease (RNase) activation which initiates 
a non-conventional mRNA splicing reaction of the pre-existing X box binding protein 1 mRNA 
(xbp1u). Spliced-XBP1 mRNA (xbp1s) is then translated to the spliced XBP1 protein (XBP1s). XBP1s 
is a transcription factor that translocates to the nucleus and initiates the transcription of UPR-related 
and non-related genes. XBP1expression is also activated by ATF6 and PERK pathways [11]. XBP1s 
can be considered a super transcription factor since its activity is associated with the expression of 
chaperones, endoplasmic reticulum-associated degradation (ERAD) proteins, XBP1 itself and 
inflammatory genes [12]. XBP1s also mediates the expression of genes involved in differentiation, 
survival, apoptosis and autophagy. In addition, IRE1α-XBP1s pathway is involved in lipid metabolism 
since activates the transcription of many lipogenic enzymes such as DGAT2 (diacylglycerol acyl 
transferase 2), SCD1 (stearoyl-CoA desaturase 1) and ACC2 (Acetyl-CoA carboxylase 2), being a 
critical regulator of hepatic lipid metabolism [13] .  
 Bearing in mind this background information, the aim of the present work was to determine 
whether hyperosmolarity activates IRE1α/XBP1s pathway in renal epithelial cells and the role of 
XBP1s transcription factor in the upregulation of lipid metabolism in renal cells submitted to 
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2. Materials and Methods 
All drugs, salts and solvents used to prepare buffers or chromatography mobile phases were of 
analytical grade and purchased from Merck Argentina. 
2.1. Culture conditions. Madin-Darby canine kidney (MDCK) cells (American Type Culture 
Collection, passages 55–58) were grown in a mixture containing DMEM (Dulbecco's modified eagle's 
medium) and Ham’s-F12 (1:1) (GIBCO
TM
), 10 % FBS (Fetal bovine serum) (Natocor
TM
), and 1 % 
antibiotic mixture (GIBCO
TM
). After reaching 70–80% confluence, cells were placed in low-serum 
medium (0.5% FBS) for 24 h and then subjected to hyperosmolarity for different periods of time (0, 6, 
12, 24 or 48 h). For isosmolar condition, the commercial medium was used. Its osmolality (298  19 
mOsmol/Kg of water), measured with an osmometer (μOSMETTE, Precision Systems; Sudsbury, 
MA), resulted from its sodium salts composition: 120 mM NaCl, 14 mM NaHCO3, 0.5 mM Na2HPO4 
(anhydrous), 0.5 mM NaH2PO4·H2O. Hyperosmolar media were made by adding aliquots of sterile 5 
M NaCl to commercial medium to achieve desired final osmolality (520  12 mOsmol/Kg of water) 
generated by sodium salts of commercial medium plus the addition of 125 mM NaCl [6, 14]. After 
treatments, media containing dead cells and debris were discarded, and cells attached to the culture 
plastic were collected after 0.25 % trypsin-EDTA (GIBCO
TM
) treatment and counted in a 
hemocytometer chamber (Neubauer´s chamber). Total and viable cells were determined by trypan blue 
exclusion test which is based on the principle that live cells possess intact cell membranes that exclude 
trypan blue whereas not viable cells do not [15]. Cells were used for western blot analysis, mRNA 
isolation and cellular fractionation. 
2.2. Analysis of XBP1 contribution to lipid synthesis. The involvement of XBP1 in 
glycerophospholipids (GP) and triglycerol-glycerolipids (GL-TG) synthesis was evaluated by using 
4µ8C (Sigma-Aldrich), a pharmacological inhibitor of IRE1α-associated endoribonuclease activity 
which is involved in the splicing of the immature xbp1 mRNA (xbp1u) [16]; or by gene silencing 
using xbp1-small interfering RNA (xbp1-siRNA) strategy. To do this, MDCK cells were grown in a 
mixture containing DMEM/Ham’s-F12 (1:1), 10 % FBS and 1 % antibiotic mixture. After reaching 
70–80% confluence, cells were placed in low-serum medium (0.5% FBS) for 24 h and, before NaCl 












6 Casali & Malvicini et al 
inhibitor uptake. After that, hyperosmolar cultures were made by supplementing media with 5 M NaCl 
up to final concentration 125 mM while isosmolar cultures were added with equal volume of sterile 
vehicle.  Then cells were incubated for extra 24 h.  
In other set of experiments, cells were transfected with xbp1-siRNA designed in our laboratory by 
using BLOCK-iT™ RNAi Designer (Thermofisher) (5’CCUCUGAGACAGAGAGCCAAGCUAA-
3’/5’-UUAGCUUGGCUCUCUGUCUCAGAGG-3’) and purchased from Invitrogen. Transfections 
were performed with lipofectamine 3000 (Invitrogen) according to manufacturer instructions. Briefly, 
MDCK cells were grown in a mixture containing DMEM/Ham’s-F12 (1:1), 10 % FBS and 1 % 
antibiotic mixture. After reaching 50% confluence, media were replaced by fresh DMEM-F12/0.5 % 
FBS without antibiotic containing a mixture of lipofectamine 3000 and an aliquot of 20 μM xbp1-
siRNA to reach final concentration of 40 nM. Cells were grown in the presence of this reactive for 5 h 
and then, transfection protocol was repeated once. After transfection, media were replaced by fresh 
DMEM-F12/0.5 % FBS and hyperosmolar cultures were made by supplementing media with 5 M 
NaCl up to final concentration 125 mM, while isosmolar cultures were added with equal volume of 
sterile vehicle. Then cells were incubated for extra 24 h. After treatments, cells were collected by 0.25 
% trypsin-EDTA treatment, counted and used for RNA extraction or for lipid metabolism analysis. 
2.3. Analysis of TonEBP participation in lipogenic genes expression. To evaluate the role of 
TonEBP transcription factor on lipogenic enzyme expression, tonebp gene was silenced before 
hyperosmolar treatment by using tonebp-siRNA duplex (5′AUGGGCGGUGCUUGCAGCUCCUU3′/ 
5′GGAGCUGCAAGC ACCGCCCAUU 3’, Invitrogen) designed by Na et al [17]. MDCK cells were 
grown in a mixture containing DMEM/Ham’s-F12 (1:1), 10 % FBS and 1 % antibiotic mixture. After 
reaching 50% confluence, media were replaced by fresh DMEM-F12/0.5 % FBS without antibiotic 
containing a mixture of lipofectamine 3000 and an aliquot of 20 M tonebp-siRNA to reach final 
concentration of 200 nM. Cells were grown in the presence of this mixture for 5 h and then, 
transfection protocol was repeated once. After transfection, media were replaced by fresh DMEM-
F12/0.5 % FBS and hyperosmolar cultures were made by supplementing media with 5 M NaCl up to 
final concentration 125 mM, while isosmolar cultures were added with equal volume of sterile vehicle. 
Then cells were incubated for extra 24 h. After treatments, cells were collected by 0.25 % trypsin-
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2.4. RNA isolation and RT-PCR analysis. MDCK cells were grown in a mixture containing 
DMEM/Ham’s-F12 (1:1), 10 % FBS and 1 % antibiotic mixture. After reaching 70-80 % confluence, 
cells were subjected to hyperosmolar media for different periods of time (6, 12, 24, 48 h, as it is 
described in 2.1.); or treated with IRE1α-associated endoribonuclease activity inhibitor 4µ8C (as 
described in 2.2); or transfected with xbp1-siRNA or tonebp-siRNA (as described in 2.2 and 2.3.) and 
then treated with hyperosmolar medium and incubated for extra 24 h. Once the incubation time had 
finalized, cells were trypsinized, collected and counted as described above (see 2.1.). In all treatments, 
2 × 10
6
 cells were used for total RNA extraction by means of the SV Total RNA Isolation System 
(Promega) in accordance with the manufacturer's instructions. First-strand cDNA was synthesized 
from total RNA by using MMLV retrotranscriptase (Promega) and oligodT (Biodynamics). To 
evaluate mRNA expression level, cDNA PCR amplification was done by using specific primers 
designed with Primer3 software (BioTools - University of Massachusetts Medical School). β-actin was 
used as loading control. Table 1 shows primers sequences, the number of cycles applied and the 
annealing temperature in each case. PCR products were resolved in 2 % agarose (Promega) gels 
containing ethidium bromide (Promega) prepared in TBE (90 mM Tris/Borate/3 mM EDTA) buffer. 
The presence of PCR products was revealed under UV light. Bands densitometries were performed 
with Gel Analyzer 19.1 online-free software.  
Table 1. Nucleotide sequences for specific primers used in PCR assays. 
Protein Primer Forward (5´3´) Primer Reverse (5´3´) Cycles         
BGT1 GAGGTAGTCCCTAGTCCCACA CACCCACAAAGTCCAGAGGT 28 58 
COX2 TCAGCCATACAGCAAATCCTT GTAGCACTAGTAGTTTAGGAGT 25 55 
SMIT GCTCATAGCCAAAGGCTCTAC TCACCACCATAAAAGCCACA 25 58 
β-Actin CAAAGCCAACCGTAGAGAAG CAGAGTCCATAGACAATACCAG 24 58 
XBP1 ACTAGCCAGAGACCGAAAGAA TCTCCGCCTCCTCTTCAGTA 24 58 
XBP1(s) ACCCTAGGCTACTAGAAGAGGA TCAACGCTAGTCAGAATCCAT 31 59.1 
CHOP CCCTCACTCTCCAGATTCCA TAGCCACTTTCCTCTCGTTCT 26 58 
BIP TCACCTCCTAGGGAACTTTTAG TTTAGTCTTCAGCGGTCACAC 26 58 
Lipin1 CGCAAGTCCTTCAGGTTCTC TGTGGAGATGACTTTGCAGC 28 64.5 
Lipin2 AAGACCAAAATAGCTTCCCCT TAGATCCCCAGAATAGGAAGAG 29 63.6 
DGAT1 TGGATAGTGAGCCGCTTCTT AGGAGCCTCATAGTGGAGCA 32 60.8 
DGAT2 AGTAGGCTCAGGCAGGTTAGA GATAGCTCTTCAAAATAGGGGA 32 63.6 
SREBP1 AGACATGGCAACCACTGTGA  GARAGRRCCRCCGCTCACCA 31 59.1 
SREBP2 GATGTCATCTGTCGGTGGTG  GGGGGCTCRCTGRRACTTCC 28 59.1 
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2.5. Metabolic labeling experiments. In order to evaluate the role of XBP1s in glycerolipid synthesis 
we studied the incorporation of [U-
14
C]-glycerol (Perkin-Elmer TM) into GP, GL-TG and GL-DG in 
MDCK cells treated either with 4µ8C or xbp1-siRNA. To do that, MDCK cells were grown in a 
mixture containing DMEM/Ham’s-F12 (1:1), 10 % FBS and 1 % antibiotic mixture. After reaching 
70–80% confluence, cells were placed in low-serum medium (0.5% FBS) for 24 h and, before NaCl 
addition, cultures were grown in the absence or in the presence of 20 M 4µ8C for 30 min to allow 
inhibitor uptake. After that, MDCK cells without or with 4µ8C were incubated in commercial media 
(isosmolar condition controls) or in hyperosmolar media for extra 24 h.  In other set of experiments, 
cells were transfected with xbp1-siRNA as described in 2.2. and after transfection treatment, media 
were replaced by fresh DMEM-F12/0.5 % FBS alone (isosm lar condition) or added with 5 M NaCl 
up to final concentration 125 mM (hyperosmolar conditions).  Then cells were incubated for extra 24 
h. In order to monitor glycerolipid de novo synthesis, 3 h before harvesting cells, 2 µCi/ml of [U-
14
C]-
glycerol were added to the media. After labeling, cells were collected and counted, and total lipids 
were analyzed as described in 2.6. Results are expressed as pmol of [
14
C-Gly]-Glycerolipids / 1 x 10
6
 
cells ± SEM.  
2.6. Lipid extraction, separation and quantitation. Total lipids were extracted by Bligh and Dyer 
method [18]. Briefly, after treatments (see 2.2.) or treatments and labelling (see 2.5.), MDCK cells 
were collected and counted, and ~3 × 10
6
 cells were suspended in 800 µl of phosphate-buffered saline 
(PBS) and mixed with 2 ml of methanol and 1 ml of chloroform, vortexed gently for 30 s, and 
incubated on ice for 15 min. To obtain two phases, 1 ml of chloroform and 1 ml of water were added, 
vortexed for 30 s and centrifuged at 800 g for 5 min. The lower organic phase containing total cell 
lipids was collected, dried under a nitrogen stream, and kept at -80°C for further analysis. Different 
lipid species were separated by thin layer chromatography (TLC). To do this, dried extracts were 
applied drop by drop onto a 1 cm lane of thin-layer silica gel chromatoplates (Merck) and developed in 
a solvent system containing a mixture of petroleum ether / hexane / ethylic ether / acetic acid 
(40:40:20:1, v/v) [7]. The different lipids were identified by comparison with the corresponding 
standards and the retention factors (Rfs): 0, 0.13 and 0.60 for glycerophospholipids (GP), 
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solvents used were of analytical grade and purchased from Merck Argentina. 
2.6. Subcellular fractionation. To evaluate the presence of XBP1s in nuclear compartment, MDCK 
cells were grown in a mixture containing DMEM/Ham’s-F12 (1:1), 10 % FBS and 1 % antibiotic 
mixture. After reaching 70–80% confluence, cells were placed in low-serum medium (0.5% FBS) for 
24 h and then, MDCK cells were incubated in commercial media (isosmolar condition) or in 
hyperosmolar media for 24 and 48 h.  MDCK cells were collected and ~ 10 × 10
6
 cells were placed in 
a cold hypotonic-lysis buffer (10 mM Hepes-KOH, pH=7.9, 1.5 mM MgCl2, 10 mM KCl and 0.4 % 
Triton X-100), and mechanically disrupted by using a 20-gauche needle syringe. Then, a 10 X solution 
A, containing 2.5 M sucrose, 250 mM Tris-HCl pH=7.4, 30 mM MgCl2, 20 mM EDTA, was added to 
each sample to reach a final concentration 0.25 M sucrose, 25 mM Tris-HCl pH=7.4, 3 mM MgCl2, 2 
mM EDTA. Samples were centrifuged at 860 g for 15 min and the resulting pellet was washed twice 
with 1 X solution A, and then resuspended in an adequate volume with 1 X solution A. Protein content 
was determined by Lowry et al. procedure [19] and then, prepared for western blot analysis. 
2.7. Western blot analysis. After hyperosmolar treatment (see 2.1.) or hyperosmolar treatment 
followed by fractionation (see 2.6.), aliquots containing 50 µg of protein were incubated with 4 × 
Laemmli buffer at 100°C for 5 min. Then, proteins were resolved in a 12.5 % SDS-polyacrylamide 
(Thermofisher) gels and blotted to polyvinylidene difluoride membranes (PVDF) (GE Healthcare Life 
science) at 100 V for 40 min. Membranes were blocked with 5 % non-fat milk in Tris-buffer saline 
(TBS:100 mM Tris-HCl, pH=7.5, 1.5 M NaCl)-1 % Tween 20 solution (TBS-Tween) and incubated 
overnight at 4°C with primary antibodies: goat polyclonal XBP1 antibody, 1:200 (Santa Cruz 
Biotechnology) or rabbit polyclonal β-Tubulin antibody, 1:5000 (AbCam). According to the 
manufacturer information, anti-XBP1 antibody (Santa Cruz Biotechnology, XBP-1 R14, SC 32136) is 
suitable for detecting both unspliced- (XBP1u) and spliced- (XBP1s) forms of XBP1 protein. After 
washing, blots were incubated with secondary antibodies: rabbit anti-goat horseradish peroxidase 
(HRP)-conjugated (1:5000) or donkey anti-rabbit HRP-conjugated 1:6000 (GE Healthcare Life 
science). Bands were evidenced by means of ECL Plus Western blotting analysis system (GE 
Healthcare Life science). Bands densitometries were performed with Gel Analyzer 19.1 online-free 
software. 
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absence or in the presence of 20 M 48C (see 2.2.) on glass coverslips. After treatments, cells were 
fixed in 4 % paraformaldehyde (Sigma-Aldrich) prepared in PBS solution for 15 min and 
permeabilized with 0.5 % triton X-100 for 10 min.  Then, samples were blocked with 3 % BSA 
(bovine serum albumin, Sigma-Aldrich) in PBS for 60 min. After blocking, cells were incubated 
overnight with primary goat polyclonal anti-XBP1 antibody (1:20, Santa Cruz Biotechnology, XBP-1 
R14, SC 32136) at 4°C. According to the manufacturer information, this antibody is suitable for 
detecting both unspliced- (XBP1u) and spliced- (XBP1s) forms of XBP1 protein. Primary interaction 
was evidenced by incubating samples with a secondary donkey anti-goat Alexa Fluor® 488 
conjugated antibody, 1:200 (Abcam); DNA was stained with 2.5 μM Hoechst 33258 (Sigma-Aldrich) 
in wet chamber for 60 min at room temperature. Then, samples were washed with PBS and mounted 
with a drop of Vectashield mounting medium (Vector Laboratories). To evaluate lipid droplets, after 
treatments, cells were fixed in 4 % paraformaldehyde prepared in PBS solution for 15 min and 
permeabilized with 0.5 % triton X-100 for 10 min.  After washing, cells were incubated with 0.5 % oil 
red O (Sigma-Aldrich) in isopropanol for 5 min. Then, samples were exhaustively washed with tap 
water and PBS. DNA was stained with 2.5 μM Hoechst 33258 (Sigma-Aldrich). Next, samples were 
mounted with a drop of Vectashield mounting medium (Vector Laboratories). Fluorescence images 
were obtained with a Nikon Eclipse Ti (with an objective Plan apo VC 60×, 1.4 DIC 1/2) with 
acquisition software Micrometrics SE Premium (Accu-Scope). Images were processed using Image J. 
2.9. Statistical analysis. The results were expressed as mean ± SEM. Data from controls and different 
treatments were analyzed by ANOVA, and significant differences were assessed by a posteriori 
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3. Results.  
3.1 Hyperosmolarity induces UPR and XBP1 activation in MDCK cells. Cells subjected to 
hyperosmolarity activate numerous adaptive mechanisms during the first 24 h after osmotic challenge 
[2, 20]. These include the expression of osmoprotective genes such as membrane cotransporters, 
sodium/myo-inositol transporter (smit) [21] and sodium/chloride/betaine transporter (bgt1) [22], both 
needed for organic osmolytes transport to counterbalance the rise in intracellular ionic strength, and 
the expression of cyclooxygenase 2 (cox2) which is involved in survival mechanisms [23, 24]. 
According to these reports, figure 1A and B show that 12 h of treatment with hyperosmolar medium 
increased bgt1 and, in a lesser extent, smit (bgt1- and smit-mRNA) levels in MDCK cells, and both 
became significantly higher respect to control value after 24 h of treatment. cox2 (cox2-mRNA) 
expression was also regulated by hyperosmolarity but with a different pattern. During the first 12 h of 
treatment, cox2 levels decreased; but after 24 h of incubation cox2 expression clearly increased respect 
to isosmolar level. It is interesting to note that maximal cox2 expression was found after 48 h of 
hyperosmolarity when both bgt1 and smit levels were minimal; this observation might evidence a 
synchronized osmoprotective gene expression. To determine whether hyperosmotic-protein synthesis 
activation may induce ER stress, the expression of UPR markers, xbp1, chop and bip/grp78, were 
determined at the mRNA level. Figures 1C and D show that hyperosmolarity induced ER stress and 
UPR activation in MDCK cells. Hyperosmolar media increased xbp1 and chop levels after 24 h and 
both remained elevated after 48 h. It is worth pointing out that the rise in UPR markers became evident 
after the increase of osmoprotective genes expression. In contrast, hyperosmolar treatment did not 
change bip/grp78-mRNA level at any experimental time assayed.  
Triggering of Inositol-Requiring-Enzyme 1 (IRE1)-UPR pathway involves the activation of 
IRE1-endoribonuclease (RNase) activity which initiates a non-conventional mRNA splicing reaction 
of the pre-existing xbp1 mRNA (xbp1u). As a result of IRE1 action, spliced-xbp1 mRNA (xbp1s) 
increases. xbp1s translation yields XBP1s protein, a transcription factor that translocates to the nucleus 
and initiates the transcription of UPR-related and non-related genes, xbp1 itself among them [10, 25]. 
In order to assess whether hyperosmolarity-increased xbp1 expression (Fig. 1C) reflects its activation, 
we determined xbp1u and xbp1s forms, XBP1 protein and its presence in nuclear compartment (Fig. 
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table 1 in Materials and Methods). Fig. 2 A shows xbp1u and xbp1s levels in isosmolar conditions (0 h 
incubation with hyperosmolar medium) and after 6, 12, 24 and 48 h of incubation in hyperosmolar 
medium. Figure 2 B shows the densitometric analysis of xbp1 bands, each bar is a stacked 
representation of xbp1u and xbp1s values (arbitrary units). As it can be seen, in isosmolarity, most 
mRNA corresponded to xbp1u (70 ± 8 % vs. 30 ± 6%, xbp1u vs xbp1s, respectively). After 6 and 12 h 
of treatment with hyperosmolar medium, the levels of total xbp1 decreased; however, the proportion of 
xbp1s after 6 and 12 h of treatment was higher than the proportion of xbp1s in isosmolar condition (41 
± 5 % and 39 ± 3 % vs. 30 ± 6%, after 6 and 12 h of treatment vs. isosmolar condition, respectively); 
24 h of hyperosmolarity induced total xbp1 expression (Fig. 1 C and D) and its splicing (Fig. 2 A and 
B). At that time, xbp1s represented 49  5 % of total mRNA being significantly higher than isosmolar 
value (30  6 %). The maximal xbp1 levels were found after 48 h of treatment and the relative 
amounts of xbp1u and xbp1s were comparable to isosmolar values (69  8 % and 31  6 % for xbp1u 
and xbp1s, respectively). The last lane corresponds to the treatment with ER stress inducer 
tunicamycin (Tm). These results evidence the increase of IRE1 associated- endoribonuclease activity 
leading to the rise in xbp1s and confirm hyperosmolar-triggering of UPR. Figure 2 C shows XBP1 
protein expression. When western blot analysis was performed from whole MDCK cell lysates, the 
only band detected corresponded to the 28 kDa XBP1u protein. The densitometric analysis showed a 
slight but significant increase of XBP1u as a function of the time, being maximal after 24 h of 
treatment (Fig. 2 C and D). However, we were not able to detect a 55 kDa band corresponding to the 
spliced form of the protein. Considering that antibody can detect both XBP1u and XBP1s proteins, we 
hypothesized that the loss of XBP1s band in western blot analysis could have been due to the low 
proportion of XBP1s form in whole lysate. We thought that the low levels of XBP1s could be detected 
if we analyzed nuclear compartment. To do that, we obtained nuclear fractions from isosmolar and 
hyperosmolar MDCK cultures by differential centrifugation and then, performed western blot analysis.  
As it is seen in figure 2 E, 24 h of hyperosmolarity increased XBP1 mature form in nuclear 
compartment, reaching a maximum after 48 h of treatment. The presence of XBP1s in nuclear 
compartment was also evidenced by fluorescence microscopy (Fig. 2 F). In isosmolar condition, most 
label was concentrated in cytoplasmic dots (Fig. 2 F) but 24 and 48 h of treatment caused the 
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demonstrate that hyperosmolarity induces ER stress, UPR and XBP1 activation. 
3.2 XBP1 expression is required for osmotic activation of lipid synthesis. The ER is the major site 
of lipid metabolism as many enzymes involved in lipid synthesis reside in ER membranes [26]. 
Although the UPR activation was originally associated to maintain the protein homeostasis in the ER, 
a growing number of studies suggest that UPR plays essential roles in maintaining lipid metabolism 
and homeostasis [27]. We previously showed that hyperosmolarity upregulates phospholipid and 
triglycerides synthesis and content in renal cells [6, 7]; Fagone et al demonstrated that cell 
differentiation occurs with activation of membrane lipid synthesis which requires XBP1 activation 
[28]. Thus, we decided to evaluate whether hyperosmolarity-induced XBP1s (Fig. 2 E and F) was 
involved in glycerolipid metabolism in MDCK cells. To do that, two different strategies were used: the 
silencing of xbp1gene and the inhibition of the IRE1α activity by 4µ8C. As it was previously reported, 
hyperosmolarity increased glycerophospholipids (GP), triglycerides (GL-TG) and diglycerides (GL-
DG) synthesis (Fig. 3 C and G). The treatment of cells with xbp1-siRNA, which reduced the 
expression of both xbp1u and xbp1s (Fig. 3A and B), significantly decreased hyperosmlarity-induced 
GL-TG synthesis (Fig. 3 C) as well as oil red-O staining (Fig. 3D). However, no changes were found 
neither in GP nor in GL-DG synthesis. The treatment of cells with 20 M 4µ8C, that inhibits the 
RNAse activity of IRE1α, completely blocked the formation of xbp1s, in both isosmolar and 
hyperosmolar conditions (Figures 3E and F). As observed with xbp1-siRNA, 4µ8C considerably 
diminished GL-TG synthesis without changes in GP synthesis, but in this case, a slight but significant 
increase in GL-DG synthesis was observed (Fig. 3 G). Such a difference, compared with the synthesis 
of GL-DG in cells treated with xbp1-siRNA, may be due to the highest efficiency of 4µ8C in blocking 
the production of xbp1s (Fig. 3E vs. Fig. 3A). No changes were observed on lipid synthesis in 
isosmolar conditions by 4µ8C treatment. The decrease in GL-TG production was reflected in the 
reduction in the number (Fig. 3I) and in the size (Fig. 3J) of lipid droplets. 
3.3. XBP1 regulates lipogenic genes expression. Hyperosmolar induction of GL-TG synthesis and 
accretion is associated to the transcriptional activation of main lipogenic enzymes such as LPIN1 and 
LPIN2, both involved in the conversion of phosphatidic acid into GL-DG; and DGAT1 and DGAT2 
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factor can modulate the expression of different lipid metabolism enzymes [29, 30]. In addition, we 
found that the inhibition of xbp1 synthesis or maturation dropped GL-TG synthesis (Fig. 3). Hence, we 
evaluated whether XBP1s regulates the transcription of lpin1 and lpin2, and dgat1 and dgat2 mRNAs. 
To do that, MDCK cells were cultured for 24 h under hyperosmolar conditions in the absence or the 
presence of xbp1-siRNA (Fig.4 A and B) or 20 µM 4µ8C (Fig. 4 C and D). Both, xbp1-siRNA and 
4µ8C decreased lpin1, lpin2 and dgat1 expression. However, no changes were observed for dgat2 
enzyme neither by using xbp1-siRNA nor by action of 4µ8C. We previously showed that 
hyperosmolarity increases the expression of the transcription factor srebp (Sterol Regulatory-Element 
Binding Protein) which mediates hyperosmolar induction of LPIN enzymes [7]. Thus, we evaluated 
the possibility that XBP1s was mediating srebp expression. As it is seen in figure 4, both xbp1-siRNA 
(Fig. 4 E and F) and RNAse inhibitor 4µ8C (Fig. 4 G and H) blocked the expression of srebp1 and 
srebp2 transcription factors. Together, these results indicate that XBP1s modulates lipogenic enzymes 
transcription by regulating the transcriptional activation of srebp transcription factor.  
3.4. The role of TonEBP in hyperosmolar-induced XBP1 expression and activity. The 
transcription factor TonEBP (Tonicity Responsive-Enhancer Binding Protein) is considered the master 
regulator of osmoprotective response in renal cells. Its expression and translocation to the nucleus is 
rapidly activated by the increase of environmental osmolarity [2, 31, 32]. Once activated, TonEBP 
mediates the expression of osmoprotective proteins such as SMIT, BGT1 and COX2, among others. 
As XBP1 expression increased after 24 h of hyperosmolar treatment, we evaluated whether TonEBP 
activity was required for osmotic induction of XBP1. To do that, tonebp-siRNA was used to impede 
its expression. As it is shown in figure 5 A, tonebp-siRNA decreased tonebp mRNA as well as the 
levels of its target genes mRNAs: smit and bgt1. tonebp silencing also decreased the expression of 
hyperosmolar-induced xbp1-mRNA (Fig. 5 B and C), which in turn caused the fall in the expression of 
srebps mRNA (Fig. 5 D, E and F). Thus, hyperosmolar activation of TonEBP drives the transcriptional 
activation of xbp1u whose maturation, translation and activity are required for the regulation of lipid 
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4. Discussion.  
The goal of the present work was to evaluate whether hyperosmolarity induces ER stress-UPR 
activation and the relationship between UPR and glycerolipid synthesis regulation in renal epithelial 
cells. The data presented herein demonstrate that hyperosmolarity activates IRE1-XBP1 pathway 
(Fig. 1 and 2), and that XBP1 regulates glycerolipid synthesis through transcriptional regulation of the 
main lipogenic enzymes (Fig. 3 and 4) by means of XBP1-induced SREBP expression (Fig. 4). We 
also evidenced the relationship between TonEBP and XBP1 (Fig. 5).  
 Physiologically, renal medullary interstitium is characterized by its high osmolarity which is 
made of high and variable concentrations of urea and NaCl. Even more, environmental osmolarity 
may abruptly vary during urine concentration process [4]. To face up to the osmolar challenge cells 
activate the biosynthesis of various membrane-associated proteins such as the transporters 
sodium/myo-inositol transporter (SMIT), sodium/chloride/betaine transporter (BGT1), epithelial 
sodium channel (ENAC), urea transporter A and B (UTA and UTB), cystic fibrosis transmembrane 




-ATPase, glucose transporter 1 and 4 (GLUT1 and GLUT4), 
water channels (AQP1-5 and AQP9), metabolic enzymes (COX2) and receptors (AT1, type 1 
angiotensin II receptor), among others [2, 21-24]. In addition, in vivo as well as in vitro experiments 
demonstrated that hyperosmolarity is a main signal for renal tubular cells differentiation and urinary 
concentrating mechanism maturation. During the first hours of hyperosmolar treatment, Madin-Darby 
Canine Kidney (MDCK) cells activates the expression of osmoprotective genes (Fig. 1 A and B). Once 
adapted, cells begin to execute a molecular program to achieve final polarized-differentiated 
phenotype that involves the increase in cell size and volume, and the formation of primary cilium  
[14]. Both processes involve a high rate of protein synthesis [2-4, 14]. Thus, it is logical to hypothesize 
that hyperosmolarity induces ER stress. Apart from unfolded proteins, IRE1 might sense lipid bilayer 
stress [33-35]. Thus, perturbations in ER-membranes by the excess of fatty acids (especially saturated 
fatty acids), either by de novo synthesis or by GL-TG hydrolysis, can directly activate IRE1 
independently of unfolded proteins [34]. It has been reported that a feature of lipid-dependent 
activation of UPR is the absence of changes in the levels of BiP chaperone [34]. We previously 
demonstrated that hyperosmolarity increases acc and fas expression and de novo fatty acids synthesis 
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physicochemical properties with the subsequent activation of IRE1 - XBP1 pathway. This possibility 
might explain the fact that BiP chaperone expression did not change with hyperosmolar treatment (Fig. 
1 C and D). However, such hypothesis must be proven. 
 We demonstrated that hyperosmolar medium induces phospholipid synthesis activity and 
phospholipid mass accretion in MDCK cells within the first 48 h of hypertonic treatment. The 
upregulation of GP synthesis is needed for membrane biogenesis during cell polarization-
differentiation processs, since it contributes to the enrichment of the apical and basolateral membranes 
in sphingomyelin (SM) and phosphatidylcholine (PC) content, respectively [6]. Here we show that 
XBP1s regulates lipogenic enzymes expression; thus, XBP1s participates in renal cell differentiation 
by activating lipid metabolism. XBP1 has been associated to eosinophils differentiation [36], adipose 
cell differentiation and myogenesis [37], cardiac myogenesis, hepatogenesis, plasma cell 
differentiation and development of secretory tissues [38, 39]. Despite it is known that XBP1 can direct 
the expression of diverse types of proteins [40], it is accepted that XBP1 promotes differentiation, at 
least in part, by regulating the biogenesis and expansion of organelles involved in secretion, including 
the ER and Golgi [41, 42]. Our results demonstrate that XBP1 directs the expression of lipogenic 
enzymes which are needed for membranes biogenesis in cell polarization and differentiation. In 
addition, we show that XBP1 expression is mediated by TonEBP (Fig. 5), which has also been 
involved in renal cell differentiation [1], skeletal muscle differentiation [43], P19CL6 cells 
differentiation to cardiomyocytes  [44], CACO-2 cell differentiation [45] and human bone marrow 
stem cells (hBMSCs) differentiation to chondrogenic cells [46]. Therefore, we can hypothesize that 
high sodium environment induces MDCK cells differentiation by activating TonEBP transcription 
factor which, at least in part, regulates XBP1 expression. In addition, XBP1 would constitute an 
osmoprotective protein since it drives the expression of lipogenic enzymes triggering a specific lipid 
synthesis program necessary for ER expansion that would restore ER homeostasis before cell 
differentiation.  
 IRE1α/XBP1s pathway was identified as a critical regulator of hepatic lipid metabolism [13]; 
XBP1s has been implicated in transcriptional regulation of many lipogenic genes such as scd1 and acc 
[30] and CDP-choline pathway [29]. Herein we show that xbp1 silencing as well as the inhibition of 
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lpin2 (Fig. 4), both involved in the generation of GL-DG needed for PC, PE and GL-TG synthesis. 
GL-DG biosynthesis was not reduced by 4µ8C (Fig. 3), probably due to a remnant preexisting lipin 
activity. GL-DG seemed to be directed to GP more than to GL-TG synthesis, thus preserving 
membrane homeostasis. Impaired GL-TG production was probably due to the decrease in dgat1 
expression and the deviation of GL-DG substrate to GP synthesis. Previous report indicate that XBP1s 
regulates the expression of DGAT2 enzyme in hepatic tissue [13]; however, in our experimental 
conditions, xbp1 maturation blockage did not decrease dgat2 expression, but decreased dgat1 (Fig. 4). 
Chitraju and coworkers demonstrated that both DGAT1 and DGAT2 contribute to GL-TG synthesis 
and storage in adipose tissue, and both can compensate for each other [47]. This is not the case in our 
system since dgat2 is not impaired by XBP1 silencing or inhibition, but GL-TG synthesis is blocked; 
moreover, GL-DG was found significantly increased (Fig. 3). 
It has been demonstrated that DGAT1, which is associated to ER membranes, has an exclusive 
role in protecting ER from the lipotoxic effect of an excess of fatty acids [48]. Considering our 
previous findings indicating that hyperosmolarity activates fatty acid synthesis [7], we can suggest that 
XBP1s contributes to ER homeostasis restoration and cell protection by activating the expression of 
dgat1 that would clearance fatty acid excess. Hence, cells subjected to hyperosmolar stress 
hyperactivate ER-associated protein synthesis, that in turn activates the ER stress sensor IRE1α. This 
protein triggers xbp1 maturation that conduce to the upregulation of fatty acid synthesis for membrane 
biogenesis; fatty acid excess is then cleaned up by LD formation. The increase in GP synthesis would, 
on one hand, provide new membrane extension to the jammed ER for carrying out the biosynthesis 
and maturation of osmoprotective proteins; the restoration of ER homeostasis would impede the 
activation of apoptotic or autophagic processes [49]. On the other hand, once ER functionality is 
restored, membrane biogenesis would be necessary for cell differentiation process, since glycerolipid, 
cholesterol and sphingolipid synthesis occur in ER membranes. Our data agree with previous reports 
showing the role of XBP1s in phosphatidylcholine synthesis, ER-membrane expansion and ER stress 
alleviation during B-lymphocyte differentiation [26, 28, 29].  
 One outstanding finding of our work was that srebp expression is mediated by XBP1s. We 
previously showed that hyperosmolarity upregulates glycerolipid synthesis due to an increase in the 
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mediated by SREBP [6-8]. Here we show for the first time that renal expression of srebp1 and srebp2 
is mediated by XBP1s (Fig. 4). Our finding agrees with the only one previous report from Ning et al. 
showing that insulin-mediated hepatic lipogenesis involved IRE1-XBP1s activation and srebp1c 
transcription upregulation [50].  
 Summarizing, in the present work we studied whether hyperosmolarity triggers ER-stress and 
UPR activation and its relationship with lipid synthesis in renal cells. Based on the present results we 
can hypothesize that the abrupt increase in the osmolarity of the environment induces signaling 
pathways that activate TonEBP transcription factor. TonEBP triggers the transcription of smit, bgt1, 
cox2 and xbp1 genes (among others). The products of these genes are membrane associated proteins 
whose synthesis occurs at endoplasmic reticulum (ER) membranes. The abrupt increase in ER-
associated protein synthesis, causes ER stress and IRE1 activation. IRE1-associated 
endoribonuclease splices xbp1u to xbp1s, which is translated to XBP1s protein. XBP1s translocates to 
the nucleus, binds to its response element in DNA and activates the transcription of srebp (among 
other genes). After its cytoplasmic translation, which also occurs at ER membranes, SREBP is 
activated, translocates to nuclear compartment and initiates the transcription of lipogenic genes: dgat1, 
lpin1, and lpin2, and as consequence, lipid synthesis is enhanced. The increase in glycerolipids content 
facilitates ER membranes expansion and alleviation of ER stress (Fig. 6). Therefore, XBP1 acts as an 
osmoprotective protein since it is activated by high osmolarity through TonEBP and it drives 
biomembranes generation and ER homeostasis restoration.  
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Figure Legends 
Figure 1. Hyperosmolarity induces changes in osmoprotective- and UPR markers-mRNA levels. 
MDCK cells were grown in a mixture containing DMEM/Ham's-F12 (1:1), 10 % FBS and 1 % 
antibiotic mixture. After reaching 70–80% confluence, cells were placed in low serum medium (0.5% 
FBS) and incubated in isosmolar media (commercial media, 298  19 mOsmol/Kg of water, no 
addition of NaCl) or in hyperosmolar media (commercial media added with sterile 5 M NaCl up to 512 
 12 mOsm/Kg of water) for 6, 12, 24 and 48 h. After treatments, cells were collected, counted and 
subjected to RNA extraction as described in Methods. Both osmoprotective genes (cox2, smit and bgt-
1) (A), and UPR activation markers (xbp1, chop and bip) (C) mRNA levels were evaluated by RT-
PCR. The images correspond to a representative experiment from three independent determinations. 
Bar graphs, B and D correspond to the densitometric analysis of the bands performed with 
GelAnalizer 19.1 online software. They represent the ratio between the values of each mRNA and -
actin (arbitrary units) and express the mean ± SEM of three independent experiments. Significant 
differences are shown within bar graphs. 
Figure 2. Hyperosmolarity induces XBP1 activation. Panel A: MDCK cells were grown in a 
mixture containing DMEM/Ham's-F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 70–
80% confluence, cells were placed in low serum medium (0.5% FBS) and incubated in isosmolar 
media (commercial media, 298 mOsmol/Kg of water, 0 h of NaCl) or in hyperosmolar media 
(commercial media added with sterile 5 M NaCl up to 512 mOsm/Kg of water) for 6, 12, 24 and 48 h.  
In order to assess whether IRE1 - XBP1 pathway was active, specific primers were designed (Table 
1, Methods) to detect unspliced- (immature) and spliced- (mature) forms of xbp1 mRNA (xbp1u and 
xbp1s) by RT-PCR. Tunicamycin (Tm) was used as a positive control of pathway activation.  
Panel B shows densitometric analysis of the gel shown in A. Each bar is a stacked representation of 
xbp1u and xbp1s values. Densitometric analysis of the bands was performed with Gel Analizer 19.1 
online software and represent the ratio between the values of xbp1u or xbp1s and -actin (arbitrary 
units). Each bar represents the mean ± SEM of three independent experiments.  
Panel C shows a representative image of three independent western blot analysis of XBP1u protein 
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ratio between XBP1u and -Tubulin (arbitrary units). Although the antibody used (goat polyclonal 
anti-XBP1 antibody, 1:200, Santa Cruz Biotechnology, XBP-1 R14, SC 32136) is reported to detect 
both XBP1 isoforms under our experimental conditions, XBP1s band (55kDa) was not evidenced, 
probably due to the low proportion of this protein in total lysates. Then, western blot analysis was 
performed in nuclear fractions obtained by cell fractionation.  
Panel E shows a representative image of cell fractionation followed by western blot analysis of XBP1. 
For this experiment, MDCK cells were grown in a mixture containing DMEM/Ham's-F12 (1:1), 10% 
FBS and 1% antibiotic mixture. After reaching 70–80% confluence, cells were placed in low serum 
medium (0.5% FBS) and incubated in isosmolar media (commercial media, 298 mOsmol/Kg of water, 
0 h of NaCl) or in hyperosmolar media (commercial media added with sterile 5 M NaCl up to 512 
mOsm/Kg of water) for 24 and 48 h. After treatment MDCK cells were collected and ~ 10 × 10
6
 cells 
were placed in a cold hypotonic-lysis buffer (10 mM Hepes-KOH, pH=7.9, 1.5 mM MgCl2, 10 mM 
KCl and 0.4 % Triton X-100), and mechanically disrupted by using a 20-gauche needle syringe. Then, 
a 10 X solution A, containing 2.5 M sucrose, 250 mM Tris-HCl pH=7.4, 30 mM MgCl2, 20 mM 
EDTA was added to each sample to reach a final concentration 0.25 M sucrose, 25 mM Tris-HCl 
pH=7.4, 3 mM MgCl2, 2 mM EDTA. Samples were centrifuged at 860 g for 15 min and the resulting 
pellet was washed twice with 1 X solution A, and then resuspended in an adequate volume for western 
blot analysis. 
Panel F shows the distribution of XBP1 protein by fluorescence microscopy. For this experiment, cells 
were grown on coverslips and after treatments (described in Materials and Methods), cells were fixed 
with 4% paraformaldehyde in PBS followed by 0.5 % triton X-100 permeabilization. 
Immunodetection was performed with goat polyclonal anti-XBP1 antibody (1:20, Santa Cruz 
Biotechnology, XBP-1 R14, SC 32136) that can detect both XBP1 isoforms. Primary interaction was 
evidenced by incubating samples with a secondary donkey anti-goat Alexa Fluor® 488 conjugated 
antibody, 1:200 (Abcam) and 2.5 μM Hoechst. Samples were mounted with a drop of Vectashield 
mounting medium (Vector Laboratories). Images were processed with Image J and are representative 
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Figure 3. The role of XBP1 in lipid metabolism. Panel A: MDCK cells were grown in a mixture 
containing DMEM/Ham's-F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 70–80% 
confluence, cells were placed in low serum medium (0.5% FBS) and then transfected with xbp1-
siRNA. After 24 h cells were subjected to hyperosmolar medium for extra 24 h. After treatment, cells 
were harvested, RNA was isolated and xbp1 mRNA was evaluated by RT-PCR analysis.  
Panel B shows the densitometric analysis of gel shown in panel A. Densitometric analysis of the bands 
was performed with Gel Analizer 19.1 online software and each bar represents the ratio between the 
values of xbp1u or xbp1s and -actin (arbitrary units). Each bar represents the mean ± SEM of three 
independent experiments. Significative results are indicated within the graph. 
Panel C: To analyze the role of XBP1 in lipid metabolism, MDCK cells were grown in a mixture 
containing DMEM/Ham's-F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 70–80% 
confluence, cells were placed in low serum medium (0.5% FBS) and then transfected with with xbp1-
siRNA. After 24 h cells were subjected to hyperosmolar medium for extra 24 h; 3 h before harvesting 
2 μCi/ml [U-
14
C]-glycerol was added to each well. After labeling, cells were collected, and lipids were 
analyzed as described in Methods. The radioactivity incorporated to each lipid was visualized by 





 cells for GP, GL-TG and GL-DG and represent the mean ± SEM of four 
independent experiments.  
Panel D: In addition, MDCK cells were grown on glass coverslips; after reaching 70–80% confluence, 
cells were placed in low serum medium (0.5% FBS) and then transfected with xbp1-siRNA. After 24 h 
cells were subjected to hyperosmolar medium for extra 24 h; after treatment, cells were fixed in 4 % 
paraformaldehyde in PBS solution and permeabilized with 0.5 % triton X-100.  After washing, cells 
were incubated with 0.5 % oil red O in isopropanol; then, samples were exhaustively washed with tap 
water and PBS. Finally, samples were mounted in the presence of 2.5 μM Hoechst 33258 (Sigma-
Aldrich) with a drop of Vectashield mounting medium (Vector Laboratories). Fluorescence images 
were obtained with a Nikon Eclipse Ti (with an objective Plan apo VC 60×, 1.4 DIC 1/2) with 
acquisition software Micrometrics SE Premium (Accu-Scope). Images were processed using Image J 
and are representative of three independent experiments.  
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F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 70–80% confluence, cells were placed 
in low serum medium (0.5% FBS) and both, isosmolar and hyperosmolar cultures were treated with 20 
µM 4µ8C, IRE1-XBP1 pathway inhibitor, for 30 min. Then cells were subjected to hyperosmolar 
medium for extra 24 h. After treatments, cells were harvested, RNA was isolated and xbp1 mRNA was 
evaluated by RT-PCR analysis.  
Panel F shows the densitometric analysis of gel shown in panel E which was performed with Gel 
Analizer 19.1 online software and each bar represents the ratio between the values of xbp1u or xbp1s 
and -actin (arbitrary units). Each bar represents the mean ± SEM of three independent experiments. 
Significative results are indicated within the graph.  
Panel G: To analyze the role of XBP1 in lipid metabolism, MDCK cells were grown in a mixture 
containing DMEM/Ham's-F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 70–80% 
confluence, cells were placed in low serum medium (0.5% FBS) and both, isosmolar and 
hyperosmolar cells were treated with 20 µM 4µ8C for 30 min before NaCl addition; 3 h before 
harvesting 2 μCi/ml [U-
14
C]-glycerol was added to each well. After labeling cells were collected and 
lipids were analyzed as described in Methods. The radioactivity incorporated to each lipid was 
visualized by radioautography and quantified by liquid scintillation counting. The results are expressed 




 cells for GP, GL-TG and GL-DG and represent the mean ± SEM 
of four independent experiments.  
Panel H. In addition, MDCK cells were grown on glass coverslips; after reaching 70–80% confluence, 
cells were placed in low serum medium (0.5% FBS) and both, isosmolar and hyperosmolar cultures 
were treated with 20 µM 4µ8C, IRE1-XBP1 pathway inhibitor, for 30 min. Then cells were subjected 
to hyperosmolar medium for extra 24 h. After treatments, cells were fixed in 4 % paraformaldehyde in 
PBS solution and permeabilized with 0.5 % triton X-100. After washing, cells were incubated with 0.5 
% oil red O in isopropanol; then, samples were exhaustively washed with tap water and PBS. Finally, 
samples were mounted in the presence of 2.5 μM Hoechst 33258 with a drop of Vectashield mounting 
medium (Vector Laboratories). Fluorescence images were obtained with a Nikon Eclipse Ti (with an 
objective Plan apo VC 60×, 1.4 DIC 1/2) with acquisition software Micrometrics SE Premium (Accu-
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Panels I and J shows the quantification of the number and the size of lipid droplets showed in Panel H. 
Estimations were performed with Image J. Statistical significance is shown in each panel.  
Figure 4. Lipid metabolism protein expression requires XBP1s activity. MDCK cells were grown 
in a mixture containing DMEM/Ham's-F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 
70–80% confluence, cells were placed in low serum medium (0.5% FBS) and then either transfected 
with xbp1-siRNA for 24 h, to knock down xbp1 (panels A, B, E and F), or treated with 20 µM 4µ8C, 
an IRE1-XBP1 pathway inhibitor for 30 min (panels C, D, G and H). Then, cells were incubated in 
isosmolar media (commercial media, 298 mOsmol/Kg of water, no addition of NaCl) or in 
hyperosmolar media (commercial media added with sterile 5 M NaCl up to 512 mOsm/Kg of water) 
for 24 h. After treatments, cells were harvested, and RNA was isolated for RT-PCR analysis. lpin 1, 
lpin2, dgat1 and dgat2 mRNA expression in the presence of xbp1-siRNA (Panel A) and in the 
presence of IRE-XBP1 pathway inhibitor (Panel C) were evaluated. srebp1 and srebp2 mRNA 
expression in the presence of xbp1-siRNA (panel E) and in the presence of IRE-XBP1 pathway 
inhibitor (Panel G) were evaluated. The images correspond to a representative experiment from three 
independent determinations. Bar graphs in panels B, D, F and H correspond to the densitometric 
analysis of the bands performed with Gel Analizer 19.1 online software. Each bar represents the ratio 
between the values of each mRNA and -actin (arbitrary units) and expresses the mean ± SEM of 
three independent experiments. Significant differences are shown within bar graphs. 
Figure 5. TonEBP is involved in xbp1-mRNA expression. MDCK cells were grown in a mixture 
containing DMEM/Ham's-F12 (1:1), 10% FBS and 1% antibiotic mixture. After reaching 70–80% 
confluence, cells were placed in low serum medium (0.5% FBS) and then transfected with tonebp- 
siRNA to silence tonebp gene. After 24 h, cells were incubated in isosmolar media (commercial 
media, 298 mOsmol/Kg of water, no addition of NaCl) or in hyperosmolar media (commercial media 
added with sterile 5 M NaCl up to 512 mOsm/Kg of water) for extra 24 h. After treatment, cells were 
harvested and RNA was isolated and followed by RT-PCR to evaluate mRNA expression of tonebp 
and its target genes smit and bgt1 (Panel A), xbp1 (Panel B) and srebp1 and srebp2 (Panel D). The 
images correspond to a representative experiment from three independent determinations. Bar graphs 
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Analizer 19.1 online software. Each bar represents the ratio between the values of each mRNA and -
actin (arbitrary units) and expresses the mean ± SEM of three independent experiments. Significant 
differences are shown within bar graphs. 
Figure 6. The role of XBP1 in osmoprotection. Changes in environmental osmolarity induce 
signaling pathways that activate TonEBP transcription factor leading to the transcription of smit, bgt1, 
cox2 and xbp1 genes. These are membrane-associated proteins whose synthesis occurs at endoplasmic 
reticulum (ER) membranes. The increase in ER-associated protein synthesis causes ER stress and 
IRE1 activation. IRE1-associated endoribonuclease splices xbp1u to xbp1s, which is translated to 
XBP1s. XBP1s translocates to the nucleus, binds to its response element (ERSE) in DNA and activates 
srebp transcription. The activation of SREBP, which is an ER membrane-associated protein, causes 
SREBP translocation to nuclear compartment and transcriptional activation of lipogenic genes: dgat1, 
lpin1, and lpin2. As consequence, lipid synthesis is enhanced, membrane expansion is facilitated, and 













30 Casali & Malvicini et al 
 
Highlights 
 XBP1 activity is modulated by hyperosmolarity. 
 XBP1 expression is regulated by TonEBP, a hyperosmolar-induced transcription 
factor. 
 XBP1 is involved in lipid synthesis through lipogenic genes upregulation. 
 XBP1 would act as an osmoprotective protein. 
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